Hematopoietic Cell Transplantation (HCT)
Showing 1 - 25 of >10,000
Hematopoietic Cell Transplantation (HCT) Trial (Tributyrin)
Not yet recruiting
- Hematopoietic Cell Transplantation (HCT)
- Tributyrin
- (no location specified)
Jul 11, 2023
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)
Not yet recruiting
- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease
- (no location specified)
Aug 4, 2023
Vascular, Endothelial, Endothelial Dysfunction Trial in Houston (Vendys II Device)
Recruiting
- Vascular
- +3 more
- Vendys II Device
-
Houston, TexasM D Anderson Cancer Center
Jun 28, 2022
Allogeneic Hematopoietic Cell Transplantation (HCT) Trial in Boston (FMT, Placebo)
Terminated
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- FMT
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Nov 3, 2021
Respiratory Failure in Pediatric Hematopoietic Cell
Recruiting
- Respiratory Failure
- Respiratory Disease
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Mar 24, 2022
Bone Marrow Transplant Complications, Hematologic Malignancy Trial in Boston (CARE Application, Usual Care)
Not yet recruiting
- Bone Marrow Transplant Complications
- Hematologic Malignancy
- CARE Application
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 1, 2023
Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)
Completed
- Multiple Myeloma
- Selinexor
- +4 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022
Allogeneic Hematopoietic Cell Transplantation For Classical
Active, not recruiting
- Lymphoma
- Non-Interventional
-
Princeton, New Jersey
- +1 more
Mar 14, 2022
Hematopoietic Cell Transplant Trial in Atlanta (Virtual exercise and rehabilitation program)
Not yet recruiting
- Hematopoietic Cell Transplant
- Virtual exercise and rehabilitation program
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jul 5, 2023
Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 4, 2023
Other Cancer Trial in Boston (ruxolitinib)
Recruiting
- Other Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Sickle Cell Disease, Thalassemia, Beta, Thalassemia Trial in United States (Fludarabine, Cyclophosphamide, Tacrolimus)
Recruiting
- Sickle Cell Disease
- +2 more
- Fludarabine
- +7 more
-
Basking Ridge, New Jersey
- +5 more
Feb 17, 2023
Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
- Hematopoietic Cell Transplantation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 30, 2022
Gastro-Intestinal Disorder Trial in Memphis (Fecal microbiota transplant (FMT))
Not yet recruiting
- Gastro-Intestinal Disorder
- Fecal microbiota transplant (FMT)
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jan 9, 2023
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))
Recruiting
- Hematologic Malignancy
- B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
-
Duarte, CaliforniaCity of Hope
Oct 20, 2023
Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)
Completed
- Multiple Myeloma
- Uproleselan
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
cGVHD Trial in Guanzhou (Belimumab (Benlysta))
Withdrawn
- cGVHD
- Belimumab (Benlysta)
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Acute GVHD (Gvhd) Grade, Hematopoietic Cell Transplantation, Fecal Microbiota Transplant Trial in Boston (Fecal Microbiota
Recruiting
- Acute Graft-Versus-Host Disease (Gvhd) Grade
- +2 more
- Fecal Microbiota Transplant
-
Boston, MassachusettsMassachusetts General Hospital
Sep 29, 2021
Hematopoietic Stem Cell Transplantation, Art Therapy, Physical Therapy Trial (Art and Physical Therapy, Physical Therapy)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- +2 more
- Art and Physical Therapy
- Physical Therapy
- (no location specified)
Aug 11, 2022
Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)
Recruiting
- Relapsed Acute Myeloid Leukemia
- Flotetuzumab
- Donor lymphocyte infusion
-
Saint Louis, MissouriWashington University School of Medicine
Sep 7, 2022
Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)
Not yet recruiting
- Hematologic Cancer
- Hematologic Malignancy
- CBT for Fatigue
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 3, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023